Changes in dopamine transporter expression in the midbrain following traumatic brain injury: An immunohistochemical and in situ hybridization study in a mouse model

Neurological Research

Volumn 36, Issue 3, 2014, Pages 239-246

  Shimada, Ryo ^a   Abe, Keiichi ^a   Furutani, Rui ^a   Kibayashi, Kazuhiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Dopamine transporter; Head trauma; In situ hybridization; Retrorubral field

Indexed keywords

DOPAMINE TRANSPORTER,; HEAD TRAUMA,; IN SITU HYBRIDIZATION; RETRORUBRAL FIELD,;

ANIMALS; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL;

EID: 84894384338     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000289     Document Type: Article

References (34)

1. Levin H, Kraus MF. The frontal lobes and traumatic brain injury. J Neuropsychiatry Clin Neurosci. 1994;6:443-54.
2. Sato H, Ikakura K, Kurokawa A, Yokota H, Fuse A, Yamamoto Y, et al. Posttraumatic parkinsonism; a case report. (Japanese). Prog Comput Imaging. 1994;16:187-91.
3. Koller WC, Wong GF, Lang A. Posttraumatic movement disorders: a review. Mov Disord. 1989;4:20-36.
4. Dahlstroem A, Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand Suppl. 1964;Suppl 232:1-55.
5. Hu Z, Cooper M, Crockett DP, Zhou R. Differentiation of the midbrain dopaminergic pathways during mouse development. J Comp Neurol. 2004;476:301-11.
6. Hasue RH, Shammah-Lagnado SJ. Origin of the dopaminergic innervation of the central extended amygdala and accumbens shell: a combined retrograde tracing and immunohistochemical study in the rat. Comp Neurol. 2002;454:15-33.
7. Gasbarri A, Sulli A, Packard MG. The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:1-22.
8. Bisaglia M, Greggio E, Beltramini M, Bubacco L. Dysfunction of dopamine homeostasis: clues in the hunt for novel Parkinson's disease therapies. FASEB J. 2013;27:2101-10.
9. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA. 1998;95:4029-34.
10. Desvignes C, Bert L, Vinet L, Denoroy L, Renaud B, Lambás-Señas L. Evidence that the neuronal nitric oxide synthase inhibitor 7-nitroindazole inhibits monoamine oxidase in the rat: in vivo effects on extracellular striatal dopamine and 3,4- dihydroxyphenylacetic acid. Neurosci Lett. 1999;261:175-8.
11. Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J Neurochem. 2003;85:898-910.
12. Bäckman CM, Malik N, Zhang Y, Shan L, Grinberg A, Hoffer BJ, et al. Characterization of a mouse strain expressing Cre recombinase from the 39 untranslated region of the dopamine transporter locus. Genesis. 2006;44:383-90.
13. Yan HQ, Kline AE, Ma X, Li Y, Dixon CE. Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. Neuroreport. 2002;13:1899-901.
14. Wagner AK, Sokoloski JE, Ren D, Chen X, Khan AS, Zafonte RD, et al. Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem. 2005;95: 457-65.
15. Brody DL, MacDonald C, Kessens CC, Yuede C, Parsadanian M, Spinner M, et al. Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury. J Neurotrauma. 2007;24:657-73.
16. Shimada R, Nakao K, Furutani R, Kibayashi K. A rat model of changes in dural mast cells and brain histamine receptor H3 expression following traumatic brain injury. J Clin Neurosci. 2012;19:447-51.
17. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995; 26:627-35.
18. Fazeli G, Oli RG, Schupp N, Stopper H. The role of the dopamine transporter in dopamine-induced DNA damage. Brain Pathol. 2011;21:237-48.
19. Nakao K, Kibayashi K, Taki T, Koyama H. Changes in the brain after intracerebral implantation of metal lead in a rat model. J Neurotrauma. 2010;27:1925-34.
20. Vikman P, Ansar S, Edvinsson L. Transcriptional regulation of inflammatory and extracellular matrix-regulating genes in cerebral arteries following experimental subarachnoid hemorrhage in rats. Laboratory investigation. J Neurosurg. 2007;107:1015-22.
21. Kerner JA, Standaert DG, Penney JB Jr, Young AB, Landwehrmeyer GB. Simultaneous isotopic and nonisotopic in situ hybridization histochemistry with cRNA probes. Brain Res Protoc. 1998;3:22-32.
22. Tanizaki Y, Sato Y, Oka H, Utsuki S, Kondo K, Miyajima Y, et al. Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma. Pathol Int. 2006;56:510-5.
23. Cox KH, DeLeon DV, Angerer LM, Angerer RC. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol. 1984;101:485-502.
24. Longhi L, Saatman KE, Raghupathi R, Laurer HL, Lenzlinger PM, Riess P, et al. A review and rationale for the use of genetically engineered animals in the study of traumatic brain injury. J Cereb Blood Flow Metab. 2001;21:1241-58.
25. Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science. 1999;283:397-401.
26. Kraus MF, Smith GS, Butters M, Donnell AJ, Dixon E, Yilong C et al. Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj. 2005;19:471-9.
27. McDowell S, Whyte J, D'Esposito M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain. 1998;121:1155-64.
28. van Bregt DR, Thomas TC, Hinzman JM, Cao T, Liu M, Bing G, et al. Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat. Exp Neurol. 2012;234:8-19.
29. Fu Y, Yuan Y, Halliday G, Rusznák Z, Watson C, Paxinos G. A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse. Brain Struct Funct. 2012;217:591-612.
30. Mejías-Aponte CA, Drouin C, Aston-Jones G. Adrenergic and noradrenergic innervation of the midbrain ventral tegmental area and retrorubral field: prominent inputs from medullary homeostatic centers. J Neurosci. 2009;29:3613-26.
31. Gasbarri A, Packard MG, Sulli A, Pacitti C, Innocenzi R, Perciavalle V. The projections of the retrorubral field A8 to the hippocampal formation in the rat. Exp Brain Res. 1996; 112:244-52.
32. Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J, et al. Global quantification of mammalian gene expression control. Nature. 2011;473:337-42.
33. Morissette M, Di Paolo T. Sex and estrous cycle variations of rat striatal dopamine uptake sites. Neuroendocrinology. 1993;58:16-22.
34. Lavalaye J, Booij J, Reneman L, Habraken JB, van Royen EA. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl Med. 2000;27:867-9.